← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2014Last known activity
Dec 24, 2025
Timeline
1880s
- Jan 1, 1887
OHSU Knight Cancer Institute— Founded
Drugs by trial phase (132 distinct, 56 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (85 own, 0 via acquisition)
Phase 1 (38 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Cranial Nerve Diseases
- Glioblastoma
- Hypersensitivity
- Laboratory Infection
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Prolymphocytic
- Leukemia, Prolymphocytic, B-Cell
- Liposarcoma
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Osteosarcoma
- Pancreatic Neoplasms
- Paresis
- Polycythemia
- Polycythemia Vera
- Prostatic Neoplasms
- Rectal Neoplasms
- Retroperitoneal Neoplasms
- Sarcoma
- Thrombocythemia, Essential
- Thrombocytosis
- Thrombosis
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Unconsciousness
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT04452136CollaboratorN/A—
- NCT04452136Sponsor investigatorN/A—
- NCT04452136Overall official - principal investigatorN/A—
- NCT07228273Sponsor investigatorPhase 2Dec 24, 2025
- NCT07228273Lead sponsorPhase 2Dec 24, 2025
- NCT07228273OfficialPhase 2Dec 24, 2025
- NCT07089940Lead sponsorEarly Phase 1Aug 1, 2025
- NCT07089940OfficialEarly Phase 1Aug 1, 2025
- NCT06895473Sponsor investigatorPhase 2Apr 1, 2025
- NCT06895473OfficialPhase 2Apr 1, 2025
- NCT06895473Lead sponsorPhase 2Apr 1, 2025
- NCT06630325Lead sponsorPhase 2Jan 1, 2025
- NCT06630325Sponsor investigatorPhase 2Jan 1, 2025
- NCT06630325OfficialPhase 2Jan 1, 2025
- NCT06504459Lead sponsorPhase 2Oct 31, 2024
Details
- Founded
- Portland, Oregon, US Jan 1, 1887
- Last known activity
- Dec 24, 2025